Lv41
508 积分 2021-01-12 加入
The fibroinflammatory response in cancer
1个月前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
1个月前
已完结
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†
1个月前
已完结
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
1个月前
已完结
Efficacy and safety of rituximab in multiple sclerosis: a systematic review and meta-analysis
1个月前
已完结
Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for Multiple Sclerosis: A Review of Clinical Considerations
1个月前
已完结
The Immune Epitope Database (IEDB): 2024 update
10个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
1年前
已完结
Targeted Degradation of PD-L1 and Activation of the STING Pathway by Carbon-Dot-Based PROTACs for Cancer Immunotherapy
1年前
已完结
Targeted Degradation of PD-L1 and Activation of the STING Pathway by Carbon-Dot-Based PROTACs for Cancer Immunotherapy
1年前
已完结
皖公网安备34019202002308
